07:04:54 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



Evitrade Health Systems Corp
Symbol EVA
Shares Issued 7,790,265
Close 2017-03-30 C$ 2.69
Market Cap C$ 20,955,813
Recent Sedar Documents

ORIGINAL: EVITRADE Announces Closing for C&C Cosmeceuticals Corp. Assets

2017-04-03 10:14 ET - News Release

EVITRADE Announces Closing for C&C Cosmeceuticals Corp. Assets



Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE:EVA, OTCQB: AXHLF) (the “Company”) announces all parties have agreed Friday March 31, 2017 is to be the effective closing date for the CBD Plant Oils Extraction company, all cannabis oils purification intellectual property and the industrial hemp / cannabis farm for the C&C Cosmeceuticals Corporation subsidiary, subject to final due diligence of the parties.

 

Contact: Ron Ozols, Director

 

EVITRADE Health Systems Corporation

(formerly Auxellence Health Corporation)

Twitter: @evitradehealth or https://twitter.com/evitradehealth

Email: info@auxellence.com

Website: http://www.auxellence.com

CSE Micro-site: http://thecse.com/en/listings/technology/evitrade-health-systems-corp

US OTC Markets: http://www.otcmarkets.com/stock/AXHLF/news

 

About EVITRADE Health (CSE: EVA, OTCQB: AXHLF)

 

EVITRADE (formerly Auxellence Health Corp.), was founded in 2013 to provide online “digital healthcare” services for resolving common health problems. The current markets are weight-loss, high blood pressure, high blood glucose and heart arrhythmia.

 

About C&C Cosmeceuticals Corp. (“C&C” a wholly owned subsidiary of the Company)

C&C was founded in 2011 to develop, manufacture and market nutraceutical and cosmeceutical personal healthcare products and services.  It was the predecessor company that acquired Auxellence Health Corporation, which is now named EVITRADE Health Systems Corp. and is a wholly owned subsidiary. On November 15, 2016, the company announced that it signed an MOU to acquire a 50 Hectare Cannabis Farm for C&C and on January 23, 2017 the company that it signed a LOI to acquire a Plant Oils Extraction firm for C&C.  On March 3, 2017 at the shareholders meeting, C&C was voted 100% in favour of to be spun off from the parent company and it was announced on March 6, 2017 that C&C was to be spun off on a 1:1 basis.  All shareholders holding shares in EVITRADE will receive shares an equal number of shares in C&C as of the record date, which shall be announced shortly.

 

Disclaimers – Forward Looking Statements

This news release contains forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators and on the OTC Markets website which is posted on www.sedar.com, http://thecse.com/en/listings/technology/evitrade-health-systems-corp, and http://www.otcmarkets.com/stock/AXHLF/filings. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.



To view this press release as a PDF file, click onto the following link:
public://news_release_pdf/EvitradeApr32017.pdf

Source: EVITRADE Health Systems Corp. (CSE:EVA, OTCQB:AXHLF)

To follow EVITRADE Health Systems Corp. on your favorite social media platform or financial websites, please click on the icons below.


 

Maximum News Dissemination by FSCwire. http://www.fscwire.com

 

Copyright © 2017 Filing Services Canada Inc.





© 2024 Canjex Publishing Ltd. All rights reserved.